GLAM
NVO

Gardner Lewis Asset Management’s Novo Nordisk NVO Stock Holding History

Gardner Lewis Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,995
Closed -$2.26M – 79
2024
Q3 		$2.26M Hold
18,995
– – 0.64% 42
2024
Q2 		$2.71M Buy
18,995
+4,955
+35% +$657K 0.74% 38
2024
Q1 		$1.8M Buy
+14,040
New +$1.67M 0.49% 47

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Gardner Lewis Asset Management's NVO Position: Q4 2024 in Review

Gardner Lewis Asset Management sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 18,995 shares — an estimated $2.26M sold.

Gardner Lewis Asset Management first reported a position in NVO in Q1 2024 and held it in 3 quarters. The position peaked at $2.71M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Gardner Lewis Asset Management reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 18,995 Novo Nordisk shares in Q4 2024, an estimated $2.26M.
  • Gardner Lewis Asset Management first reported a position in Novo Nordisk in Q1 2024 and held it in 3 quarters.
  • Gardner Lewis Asset Management's Novo Nordisk position peaked at $2.71M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.